CD274 and neoplasm: Relevant studies have found that the increase in the expression of tumor-infiltrating T cells and PD-L1 in metastatic osteosarcoma is significantly higher than that in the primary lesion, suggesting that patients with metastatic osteosarcoma may benefit from T cell-based immunotherapy [33].